Persistence of Crystals in Stored Synovial Fluid Samples

J Rheumatol. 2020 Sep 1;47(9):1416-1423. doi: 10.3899/jrheum.190468. Epub 2020 Feb 1.

Abstract

Objective: Lack of access to polarized light microscopy is often cited as an argument to justify the clinical diagnosis of crystal-related arthritis. We assessed the influence of time since sampling and preservation methods on crystal identification in synovial fluid (SF) samples under polarized light microscopy.

Methods: This was a prospective, longitudinal, observational factorial study, analyzing 30 SF samples: 12 with monosodium urate (MSU) crystals and 18 with calcium pyrophosphate (CPP) crystals. Each SF sample was divided into 4 subsamples (120 subsamples in total). Two were stored in each type of preserving agent, heparin or ethylenediamine tetraacetic acid (EDTA), at room temperature or at 4°C. Samples were analyzed the following day (T1), at 3 days (T2), and at 7 days (T3) by simple polarized light microscopy, and the presence of crystals was recorded.

Results: The identification of crystals in the MSU group was similar between groups, with crystals observed in 11/12 (91.7%) room temperature samples and in 12/12 (100%) refrigerated samples at T3. Identification of CPP crystals tended to decrease in all conditions, especially when preserved with EDTA at room temperature [12/18 (66.7%) at T3], while less reduction was seen in refrigerated heparin-containing tubes.

Conclusion: Preserving samples with heparin in refrigerated conditions allows delayed microscopic examination for crystals. Avoiding crystal-proven diagnosis because of the immediate unavailability of microscopy no longer appears justified.

Keywords: CALCIUM PYROPHOSPHATE CRYSTALS; CRYSTAL-RELATED ARTHRITIS; MONOSODIUM URATE CRYSTALS; SYNOVIAL FLUID STORAGE.

Publication types

  • Observational Study

MeSH terms

  • Calcium Pyrophosphate*
  • Crystallization
  • Humans
  • Prospective Studies
  • Synovial Fluid*
  • Uric Acid

Substances

  • Uric Acid
  • Calcium Pyrophosphate